Valneva’s 2024 Universal Registration Document – available in its entirety in French – includes the Company’s 2024 Annual Financial Report, the Company's Annual Management Report, the Board of ...
Valneva (VALN) this morning filed with the Securities and Exchange Commission a prospectus which covers the offering, issuance and sale from ...
Valneva will provide 40,000 doses of its chikungunya vaccine Ixchiq to French overseas territory La Réunion as part of efforts to curb the spike in disease cases on the island. Valneva confirmed ...
Shares of Valneva SE (NASDAQ:VALN – Get Free Report) gapped down before the market opened on Tuesday after Guggenheim lowered their price target on the stock from $17.00 to $15.00. The stock had ...
Thank you. Hello, and thank you for joining us to discuss Valneva’s Full Year 2024 Results and Corporate Update. It’s my pleasure to welcome you today. In addition to our press release and ...
Saint-Herblain (France), March 20, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported its consolidated financial results for the year ended ...
Shares of VALN stock opened at $7.17 on Friday. Valneva has a 1 year low of $3.62 and a 1 year high of $9.50. The firm’s fifty day simple moving average is $6.34 and its 200 day simple moving ...
During the last three months, 6 analysts shared their evaluations of Valneva VALN, revealing diverse outlooks from bullish to bearish. The following table provides a quick overview of their recent ...
CEO Thomas Lingelbach highlighted that Valneva achieved double-digit year-on-year sales growth, with total product sales surpassing €160 million for 2024, in line with guidance. The company ...
Saint-Herblain (France), March 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 24, 2025, of its 2024 Universal ...
Valneva, a company specializing in vaccine development, reported strong financial results for the first quarter of 2024. The company achieved a significant year-over-year increase in product sales ...